Paolo Augusto Paoletti

Paolo Augusto Paoletti currently works at Genmab A, as Independent Director from 2015, Biomed Ltd., as Director, Akamis Bio Ltd., as Non-Executive Director, and Grid Therapeutics LLC, as Director.
Dr. Paoletti also formerly worked at Kesios Therapeutics Ltd., as Chairman & Chief Executive Officer from 2015 to 2017, Gammadelta Therapeutics Ltd., as Chief Executive Officer & Director, Forma Therapeutics, Inc., as Director, Forma Therapeutics Holdings, Inc., as Independent Non-Executive Director from 2015 to 2021, NuCana Plc, as Non-Executive Director, Eli Lilly & Co., as Vice President-Oncology Research, GSK Plc, as President-Oncology Division from 2013 to 2015, and Lilly Oncology, as Vice President-Clinical Development.
Dr. Paoletti received his doctorate degree from the University of Pisa.